Atara Biotherapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA
ATRA chart
What traders are saying about $ATRA
Latest postsAtara Biotherapeutics, Inc. news
- Trading Systems Reacting to (ATRA) Volatility
Stock Traders Daily ·
- Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
ACCESS Newswire ·
- Price to earnings forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA
TradingView ·
- Atara Biotherapeutics, Inc. Estimates – NASDAQ:ATRA
TradingView ·
- Atara Biotherapeutics Defendants Move to Dismiss Amended Securities Class Action Over Tab-cel FDA Rejection
TipRanks ·
- ATRA Q3'26 Earnings: revenue estimate is 800.00K USD
TradingView ·
- Atara Biotherapeutics (ATRA) Edges Up 2.07% to $9.35, Sitting Squarely at the Midpoint of Its Range - Vanna Flow
https://www.siam.in/ ·
- Atara Biotherapeutics Reports that the Resubmitted Tabelecleucel (Tab-cel®) Biologics License Application Has Been Accepted by the U.S. Food and Drug Administration
Yahoo Finance ·
- Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration
Yahoo Finance ·
- Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress
Yahoo Finance ·
- Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End
Yahoo Finance ·
- Atara Biotherapeutics Announces Changes to Its Board of Directors
Yahoo Finance ·
Atara Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $120.8M | $128.9M | $8.6M | – |
| Net income | $32.7M | -$85.4M | -$276.1M | -$228.3M |
| Diluted EPS | $2.57 | $-11.41 | $-65.19 | $-2.24 |
| Total assets (year end) | $20.2M | $109.1M | $165.5M | $376.4M |
| Cash and equivalents (year end) | $8.5M | $25.0M | $25.8M | $92.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Atara Biotherapeutics, Inc.
- Ticker
- ATRA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Thousand Oaks, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1604464
Frequently asked questions
What exchange is Atara Biotherapeutics, Inc. listed on?
Atara Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol ATRA.
What industry is Atara Biotherapeutics, Inc. in?
Atara Biotherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Atara Biotherapeutics, Inc. headquartered?
Atara Biotherapeutics, Inc.'s business address on file with the SEC is in Thousand Oaks, CA.
When does Atara Biotherapeutics, Inc.'s fiscal year end?
Atara Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Atara Biotherapeutics, Inc. report?
Atara Biotherapeutics, Inc. reported $120.8M in revenue for calendar year 2025, according to its SEC filings.